Locations:
Min Investment:
Max Investment:
Target Investment:
Total Funding: $230M
Total Funding:
Total Funding: $190M
Total Funding: $130M
Total Funding: $40M
Total Funding: $140M
Total Funding: $95M
Total Funding: $290M
Total Funding: $62M
Total Funding: $68M
Total Funding: $65M
Total Funding: $88M
Total Funding: $16M
Total Funding: $23M
2017
Founded in 2017, The Silverstein Foundation for Parkinson's with GBA actively pursues and invests in cutting edge research with the goal of discovering new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA) mutation carriers.
1999
1999